The DNAJB1-PRKACA fusion transcript is the oncogenic driver in fibrolamellar hepatocellular carcinoma, a lethal disease with limited therapeutic options. This evidence concerns the gene DNAJB1 and fibrolamellar hepatocellular carcinoma.